Loading stock data…
Alamar Biosciences, Inc. (ALMR)
$25.88-0.01 (-0.04%)
Market ClosedLast close Jul 24
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases.
Historical Price
Price (Candle)
Synthesizing Whystock Narrative...
Quarterly Financials
| Metric (USD) | Q1 2026 | Q1 2025 |
|---|---|---|
| Total Revenue | $26.04M↑ | $13.09M |
| Gross Profit | $14.46M↑ | $6.39M |
| Operating Income | -$12.35M↓ | -$8.55M |
| Net Income | -$21.32M↓ | -$7.66M |
Peer Comparison
JNJUNHPFE
Fundamentals
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects an...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.40B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
16.28%
Volume
Today's trading volume
242,908
Recent News
Braveheart, Attovia join next wave of biotech IPOs
The heart drug developer and immune disease specialist aim to capitalize on momentum that’s already yielded several big-ticket IPOs this year.
Alamar Hits A High Note On Alzheimer's Buzz
If you’re an Alamar Biosciences (ALMR) shareholder, Friday was a good day. The stock climbed +7.3%, closing the session at a new 52-week high of $28.42. That’s a tidy gain on a day when the S&P 500 barely nudged up +0.4% and some key industry peers actually lost ground.
Cathie Wood Doubles Down on AI, Loads Up on Tesla, Palantir, and SpaceX
Cathie Wood Loads Up on AI Winners, Cuts Roku and China Exposure
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
The aggressive growth fund investor was busy adding to some of her established stakes on Monday.
Evaluating Alamar Biosciences (ALMR) Valuation As Shares Show Modest Year To Date Gains
What Alamar Biosciences stock is telling you right now Alamar Biosciences (ALMR) has attracted fresh attention after recent trading left the stock with a last close of US$23.01 and a year to date gain of 4.59%, against mixed shorter term returns. For context, the stock was roughly flat over the past day, gained 0.17%, but declined 3.48% over the past week. Month and past 3 months performance data is not available, so short term momentum beyond these windows is harder to compare. See our...